These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 21411757

  • 1. Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas.
    Vrzalikova K, Vockerodt M, Leonard S, Bell A, Wei W, Schrader A, Wright KL, Kube D, Rowe M, Woodman CB, Murray PG.
    Blood; 2011 Jun 02; 117(22):5907-17. PubMed ID: 21411757
    [Abstract] [Full Text] [Related]

  • 2. Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas.
    Ramakrishnan R, Donahue H, Garcia D, Tan J, Shimizu N, Rice AP, Ling PD.
    PLoS One; 2011 Jun 02; 6(11):e27271. PubMed ID: 22102884
    [Abstract] [Full Text] [Related]

  • 3. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
    Blaschke S, Hannig H, Buske C, Kaup FJ, Hunsmann G, Bodemer W.
    J Med Virol; 2001 Sep 02; 65(1):114-20. PubMed ID: 11505452
    [Abstract] [Full Text] [Related]

  • 4. BLIMP1α, the master regulator of plasma cell differentiation is a tumor supressor gene in B cell lymphomas.
    Vrzalikova K, Woodman CB, Murray PG.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Mar 02; 156(1):1-6. PubMed ID: 22580854
    [Abstract] [Full Text] [Related]

  • 5. Epstein-Barr virus induces global changes in cellular mRNA isoform usage that are important for the maintenance of latency.
    Homa NJ, Salinas R, Forte E, Robinson TJ, Garcia-Blanco MA, Luftig MA.
    J Virol; 2013 Nov 02; 87(22):12291-301. PubMed ID: 24027308
    [Abstract] [Full Text] [Related]

  • 6. STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma.
    Kis LL, Gerasimcik N, Salamon D, Persson EK, Nagy N, Klein G, Severinson E, Klein E.
    Blood; 2011 Jan 06; 117(1):165-74. PubMed ID: 20876453
    [Abstract] [Full Text] [Related]

  • 7. Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment.
    Cohen M, De Matteo E, Narbaitz M, Carreño FA, Preciado MV, Chabay PA.
    Int J Cancer; 2013 Apr 01; 132(7):1572-80. PubMed ID: 22987474
    [Abstract] [Full Text] [Related]

  • 8. Restricted TET2 Expression in Germinal Center Type B Cells Promotes Stringent Epstein-Barr Virus Latency.
    Wille CK, Li Y, Rui L, Johannsen EC, Kenney SC.
    J Virol; 2017 Mar 01; 91(5):. PubMed ID: 28003489
    [Abstract] [Full Text] [Related]

  • 9. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH, Wolf H, Minarovits J.
    Autoimmunity; 2008 May 01; 41(4):298-328. PubMed ID: 18432410
    [Abstract] [Full Text] [Related]

  • 10. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
    Park CH, Kim HR, Kim J, Jang SH, Lee KY, Chung GH, Jang YS.
    J Cell Biochem; 2004 Mar 01; 91(4):777-85. PubMed ID: 14991769
    [Abstract] [Full Text] [Related]

  • 11. IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter.
    Kis LL, Salamon D, Persson EK, Nagy N, Scheeren FA, Spits H, Klein G, Klein E.
    Proc Natl Acad Sci U S A; 2010 Jan 12; 107(2):872-7. PubMed ID: 20080768
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of Epstein-Barr Virus Replication in Human Papillomavirus-Immortalized Keratinocytes.
    Guidry JT, Myers JE, Bienkowska-Haba M, Songock WK, Ma X, Shi M, Nathan CO, Bodily JM, Sapp MJ, Scott RS.
    J Virol; 2019 Jan 15; 93(2):. PubMed ID: 30381489
    [Abstract] [Full Text] [Related]

  • 13. LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.
    Bentz GL, Moss CR, Whitehurst CB, Moody CA, Pagano JS.
    J Virol; 2015 Aug 15; 89(15):7465-77. PubMed ID: 25948750
    [Abstract] [Full Text] [Related]

  • 14. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.
    Price AM, Messinger JE, Luftig MA.
    J Virol; 2018 Jan 15; 92(2):. PubMed ID: 29118124
    [Abstract] [Full Text] [Related]

  • 15. EBV epigenetically suppresses the B cell-to-plasma cell differentiation pathway while establishing long-term latency.
    Styles CT, Bazot Q, Parker GA, White RE, Paschos K, Allday MJ.
    PLoS Biol; 2017 Aug 15; 15(8):e2001992. PubMed ID: 28771465
    [Abstract] [Full Text] [Related]

  • 16. Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.
    Kis LL, Takahara M, Nagy N, Klein G, Klein E.
    Immunol Lett; 2006 Apr 15; 104(1-2):83-8. PubMed ID: 16386314
    [Abstract] [Full Text] [Related]

  • 17. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.
    Kingma DW, Weiss WB, Jaffe ES, Kumar S, Frekko K, Raffeld M.
    Blood; 1996 Jul 01; 88(1):242-51. PubMed ID: 8704180
    [Abstract] [Full Text] [Related]

  • 18. Determination of frequency of epstein-barr virus in non- Hodgkin lymphomas Using EBV latent membrane protein 1 (EBV-LMP1) immunohistochemical staining.
    Ishtiaq S, Hassan U, Mushtaq S, Akhtar N.
    Asian Pac J Cancer Prev; 2013 Jul 01; 14(6):3963-7. PubMed ID: 23886215
    [Abstract] [Full Text] [Related]

  • 19. A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus.
    Feederle R, Linnstaedt SD, Bannert H, Lips H, Bencun M, Cullen BR, Delecluse HJ.
    PLoS Pathog; 2011 Feb 01; 7(2):e1001294. PubMed ID: 21379335
    [Abstract] [Full Text] [Related]

  • 20. Current Trends and Alternative Scenarios in EBV Research.
    Minarovits J, Niller HH.
    Methods Mol Biol; 2017 Feb 01; 1532():1-32. PubMed ID: 27873264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.